Post by
blog on Nov 18, 2010 11:33am
I wonder
If voclosporin is a better drug we should expect between 1 and 3 billion in sales after completion of all indications. One of the short term issues I wonder about is what’s up with uveitis and psoriasis. These two may actually bring in revenue in a relatively short period on time.